STAT3 and esophageal cancer: Previous studies have shown that GSK3β functions in the phosphorylation-dependent activation of STAT3[195,196] and that inhibition of GSK3β attenuates the progression of gastric and esophageal cancers by suppressing STAT3 activity[197,198].